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The ubiquitin ligase Cullin5SOCS2 
regulates NDR1/STK38 stability 
and NF-κB transactivation
Indranil Paul1, Tanveer S. Batth1, Diego Iglesias-Gato2, Amna Al-Araimi3, Ibrahim Al-
Haddabi3, Amira Alkharusi3, Gunnar Norstedt3,4, Jesper V. Olsen1, Fahad Zadjali3 & 
Amilcar Flores-Morales1,2
SOCS2 is a pleiotropic E3 ligase. Its deficiency is associated with gigantism and organismal lethality 
upon inflammatory challenge. However, mechanistic understanding of SOCS2 function is dismal due 
to our unawareness of its protein substrates. We performed a mass spectrometry based proteomic 
profiling upon SOCS2 depletion and yield quantitative data for ~4200 proteins. Through this screen 
we identify a novel target of SOCS2, the serine-threonine kinase NDR1. Over-expression of SOCS2 
accelerates turnover, while its knockdown stabilizes, endogenous NDR1 protein. SOCS2 interacts with 
NDR1 and promotes its degradation through K48-linked ubiquitination. Functionally, over-expression 
of SOCS2 antagonizes NDR1-induced TNFα-stimulated NF-κB activity. Conversely, depletion of NDR1 
rescues the effect of SOCS2-deficiency on TNFα-induced NF-κB transactivation. Using a SOCS2−/− mice 
model of colitis we show that SOCS2-deficiency is pro-inflammatory and negatively correlates with 
NDR1 and nuclear p65 levels. Lastly, we provide evidence to suggest that NDR1 acts as an oncogene in 
prostate cancer. To the best of our knowledge, this is the first report of an identified E3 ligase for NDR1. 
These results might explain how SOCS2-deficiency leads to hyper-activation of NF-κB and downstream 
pathological implications and posits that SOCS2 induced degradation of NDR1 may act as a switch in 
restricting TNFα-NF-κB pathway.
The suppressor of cytokine signaling 2 (SOCS2) is one of the substrate recognition modules of Cullin5/Rbx2 
ubiquitin ligases. Classically, SOCS2 has been well-studied for its regulatory role on growth hormone (GH) sig-
naling1,2. However, subsequent studies have found that this E3 ligase is an important regulator of inflammation. 
SOCS2 function is vital for maintaining immune homeostasis and its defects have been implicated in sepsis 
related mortality in mice models due to an exacerbated inflammatory response3,4. NF-κ B signaling is centrally 
important to inflammatory processes5 and consequently, functional interactions between SOCS2 and NF-κ B 
signaling have been studied6,7. We have previously described an inhibitory role of SOCS2 on NF-κ B activation in 
macrophages and a recent study describe a similar finding in brain astrocytes8,9.
At the molecular level our understanding of SOCS2 function is limited. This is, in part, due to the pleiotropic 
nature of SOCS210–12; but mostly due to our unawareness about its physiological protein substrates. Apart from 
GH receptor, substrates identified for SOCS2 till date, with relevance to inflammation, includes SOCS313 and 
p-Pyk214. SOCS2 destabilized SOCS3 and enhanced STAT signaling in response to IL-2/3 in T cells. Similarly, 
SOCS2 augmented IL-15 induced NK cell priming by degrading phospho-(Y402)-Pyk2. The status of NF-κ B 
signaling were not evaluated in these studies. Clearly, the mechanisms of action of SOCS2 with respect to NF-κ B 
signaling needs further exploration.
In order to identify and characterize bona-fide targets of SOCS2 we utilized mass spectrometry to quantify 
protein levels for thousands of proteins in cells depleted of SOCS2. This investigation lead to the identification 
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of a number of proteins that could mediate the interplay between SOCS2 and NF-κ B. In this investigation, the 
relationship between SOCS2 and NDR1 and its consequence for NF-κ B activation is explored in detail.
Results
Quantitative proteomic screen of SOCS2 depleted cells identifies novel putative targets. We 
began our study by performing an unbiased proteomic screen to identify potential substrates of SOCS2. 
Physiological substrates of SOCS2 that are degraded in its presence are expected to accumulate when SOCS2 
is depleted. We used an RNAi knock-down approach to avoid secondary effects of long-term SOCS2 depletion. 
Expression of SOCS2 was quantitated using immunoblotting (IB) (Fig. 1A). The overall effect on cell prolifera-
tion was measured by FACS (Fig. 1B), showing minor effects in the cell cycle upon SOCS2 depletion in mouse 
embryonic fibroblasts (MEFs). We characterized the proteome of SOCS2 wild-type (SOCS2WT) and knock-down 
(SOCS2KD) MEFs using nanoLC-MS/MS (nanoscale liquid chromatography coupled to tandem mass spectrom-
etry) based proteomics (Fig. 1C). Three independent experiments were carried out using two different siRNAs 
against SOCS2, resulting in biological triplicates of essentially two biological groups. MS data of the biological 
triplicates from both groups were combined and analyzed by using a combination of MaxQuant and Perseus (see 
Methods). Relative label-free quantification (LFQ) was fairly reproducible between the triplicates, while some 
variation was observed across the different groups as depicted by principle component analysis (Fig. 1D). Overall, 
using this approach we detected ~5000 proteins and document quantitative data for > 4200 proteins upon SOCS2 
depletion (Fig. 1E). Expression of most proteins (94.6%) were unaltered and only a very small subset of proteins 
(5.4%), which satisfied the criteria of a fold-change (± ) of ≥ 1.5 and P-value < 0.05, showed differences between 
SOCS2WT and SOCS2KD MEFs (Table 1 and Table S1). No expression of SOCS2 or its previously identified target, 
the GHR (growth hormone receptor), was detected most likely due to their low abundances15.
Both endogenous and exogenously expressed NDR1 is destabilized by SOCS2. Bioinformatics 
analysis and text mining of significantly upregulated proteins in our dataset identified a handful of proteins 
previously associated with the regulation of NF-κ B activity (See Fig. 1E). Literature review indicated that FER, 
GOLPH3 and STK38 upregulates NF-κ B activity16–18. Given the recently published link between NDR1(STK38) 
Figure 1. Global identification of proteins upregulated by SOCS2 depletion. (A) MEFs were transfected 
with either a non-targeting (NT) siRNA or three different siRNAs against SOCS2. Cell lysates were prepared 
36 hrs after transfection and immunoblotted (IB) with the indicated antibodies. Numbers indicate % remaining 
protein, SOCS2/β -actin. (B) FACS analysis of MEFs transfected with si-SOCS2 #8. (C) Schematics of the 
proteomic workflow. (D) Principal component analysis of si-Control, si-SOCS2 #2 and si-SOCS2 #8 samples 
using LFQ intensities by the Perseus platform (n = 3). (E) Volcano plot of distribution of proteins identified in 
this study. Upregulated proteins (P-value < 0.05 and Fold change > 1.5) reported in the literature to have a direct 
functional link with NF-κ B are annotated. Right panel enlists genes corresponding to the annotated proteins 
which regulates NF-κ B activity. “Fold change” and “unique peptides” are indicated.
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Majority 
protein IDs Protein names
Gene 
names
P value  
(−Log10)
Difference 
(Log2)
Unique 
peptides
Mol. weight 
[kDa]
Q8K298 Actin-binding protein anillin Anln 5.145 2.026 18 122.79
Q9CYW4 Haloacid dehalogenase-like hydrolase domain-containing protein 3 Hdhd3 1.899 1.633 4 28.027
Q3TFD2 Lysophosphatidylcholine acyltransferase 1 Lpcat1 2.301 1.605 3 54.649
Q78XF5 Oligosaccharyltransferase complex subunit OSTC Ostc 3.778 1.604 2 16.815
Q9D3D9 ATP synthase subunit delta, mitochondrial Atp5d 2.552 1.560 5 17.6
Q9CR41 Huntingtin-interacting protein K Hypk 2.786 1.560 4 14.679
Q05CN2 Ribosomal RNA processing protein 1 homolog A Rrp1 1.762 1.529 4 42.904
Q9CXG3 Peptidyl-prolyl cis-trans isomerase-like 4 Ppil4 2.440 1.485 10 57.23
Q0KL02 Triple functional domain protein Trio 2.018 1.398 7 288.71
Q80ZX0 Protein Sec24b Sec24b 2.144 1.358 9 135.55
Q5XF89 Probable cation-transporting ATPase 13A3 Atp13a3 2.296 1.339 3 137.47
Q9CR27 WASH complex subunit CCDC53 Ccdc53 2.265 1.323 3 21.092
F2Z4B3 Cyclin-dependent kinase 2-associated protein 1 Cdk2ap1 2.562 1.258 3 9.6308
Q4KML4 Costars family protein ABRACL Abracl 4.853 1.254 5 9.0303
P16254 Signal recognition particle 14 kDa protein Srp14 3.115 1.250 6 12.51
Q8CHT1 Ephexin-1 Ngef 4.329 1.243 6 71.415
Q99LC8 Translation initiation factor eIF-2B subunit alpha Eif2b1 1.667 1.217 7 33.816
Q3TME9 Tyrosine-protein kinase Fer Fer 3.260 1.209 4 45.071
Q6ZQK0 Condensin-2 complex subunit D3 Ncapd3 3.285 1.189 12 169.43
Q8BW84 Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial Pet112 3.543 1.180 5 61.509
E9Q555 E3 ubiquitin-protein ligase RNF213 Rnf213 2.675 1.138 18 584.49
Q8R5C5 Beta-centractin Actr1b 1.997 1.098 6 42.281
Q9DCJ5 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 Ndufa8 3.935 1.098 5 19.992
Q8BGB7 Enolase-phosphatase E1 Enoph1 2.729 1.096 3 25.358
Q52L97 Importin subunit alpha Kpna2 4.766 1.053 14 57.927
P62077 Mitochondrial import inner membrane translocase subunit Tim8 B Timm8b 4.695 1.034 3 9.2864
Q99LT0 Protein dpy-30 homolog Dpy30 3.094 1.015 4 11.213
E9PY48 Condensin-2 complex subunit H2 Ncaph2 1.970 1.010 4 65.309
Q9EPL8 Importin-7 Ipo7 4.506 0.978 20 119.49
Q9DAS3 Dynein light chain Tctex-type 1 Dynlt1f 3.252 0.960 3 11.625
Q91WK1 SPRY domain-containing protein 4 Spryd4 2.463 0.937 7 23.275
Q6P4T3 Eyes absent homolog 3 Eya3 2.519 0.924 13 57.854
Q9D1R2 Protein KTI12 homolog Kti12 1.877 0.905 4 38.444
D5MCW4 Protein CutA Cuta 3.344 0.897 3 16.453
Q543N6 Serine/threonine-protein phosphatase 2 A activator Ppp2r4 2.280 0.897 15 36.71
Q9CRT8 Exportin-T Xpot 2.742 0.888 15 109.73
A2AEB4 Mortality factor 4-like protein 2 Morf4l2 2.734 0.886 6 22.919
Q9CQK7 RWD domain-containing protein 1 Rwdd1 2.170 0.884 6 27.785
D3YYC2 Dr1-associated corepressor Drap1 3.189 0.863 4 17.587
Q8CC06 Integrin alpha-6 Itga6 2.066 0.859 12 119.6
Q3UB06 SRSF protein kinase 1 Srpk1 4.142 0.856 10 73.088
Q9D7A8 Armadillo repeat-containing protein 1 Armc1 2.063 0.851 4 31.246
Q9CZ30 Obg-like ATPase 1 Ola1 3.529 0.846 21 44.729
P08030 Adenine phosphoribosyltransferase Aprt 3.618 0.844 12 19.724
Q5SSZ5 Tensin-3 Tns3 3.978 0.840 1 58.725
Q3UTL4 High affinity cationic amino acid transporter 1 Slc7a1 2.364 0.835 3 67.107
Q8VDF2 E3 ubiquitin-protein ligase UHRF1 Uhrf1 3.938 0.829 20 87.555
Q9CPY1 39 S ribosomal protein L51, mitochondrial Mrpl51 3.421 0.822 4 15.103
Q6PE15 Mycophenolic acid acyl-glucuronide esterase, mitochondrial Abhd10 2.757 0.821 6 33.04
Q548K2 Alcohol dehydrogenase class 4 mu/sigma chain Adh7 2.849 0.819 9 39.837
Q9CY16 28 S ribosomal protein S28, mitochondrial Mrps28 3.494 0.817 7 20.52
Continued
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Majority 
protein IDs Protein names
Gene 
names
P value  
(−Log10)
Difference 
(Log2)
Unique 
peptides
Mol. weight 
[kDa]
G3XA18 N-acylethanolamine-hydrolyzing acid amidase Naaa 1.903 0.807 3 39.803
Q8R5H1 Ubiquitin carboxyl-terminal hydrolase 15 Usp15 4.365 0.803 28 112.32
Q3UMQ8 H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 2.307 0.802 3 53.245
O70591 Prefoldin subunit 2 Pfdn2 4.651 0.798 7 16.534
Q8C845 EF-hand domain-containing protein D2 Efhd2 1.873 0.795 7 26.8
Q6P9R1 ATP-dependent RNA helicase DDX51 Ddx51 3.675 0.791 14 70.367
E9PUB0 Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 Arap1 2.705 0.780 8 83.2
Q7TMR0 Lysosomal Pro-X carboxypeptidase Prcp 5.910 0.777 13 55.026
Q9JJ44 DUTPase Dut 3.584 0.777 7 17.414
Q921M8 Ubiquitin carboxyl-terminal hydrolase Usp4 1.494 0.769 20 103.75
E9PX53 Serine/threonine-protein phosphatase 4 regulatory subunit 1 Ppp4r1 1.509 0.765 8 104.5
Q9D046 Centrin-3 Cetn3 2.665 0.762 3 19.447
Q99LZ3 DNA replication complex GINS protein SLD5 Gins4 1.888 0.760 4 25.961
Q9JKB3 Y-box-binding protein 3 Ybx3 3.254 0.757 1 38.813
Q6PDL0 Cytoplasmic dynein 1 light intermediate chain 2 Dync1li2 2.409 0.754 9 54.218
Q80 × 98 DEAH (Asp-Glu-Ala-His) box polypeptide 38 Dhx38 2.570 0.754 19 140.62
Q561N4 Ubiquitin-conjugating enzyme E2 L3 Ube2l3 1.881 0.746 1 17.861
Q8C6I2 Succinate dehydrogenase assembly factor 2, mitochondrial Sdhaf2 3.361 0.745 6 19.431
Q8K2A7 Integrator complex subunit 10 Ints10 2.772 0.739 10 82.019
Q8K4L0 ATP-dependent RNA helicase DDX54 Ddx54 1.902 0.739 13 97.747
Q5SW19 Clustered mitochondria protein homolog Cluh 3.374 0.736 13 148.07
Q6A009 E3 ubiquitin-protein ligase listerin Ltn1 2.232 0.729 10 198.92
Q545F0 Macrophage migration inhibitory factor Mif 3.086 0.728 9 12.504
Q9DBY0 Forkhead box protein P4 Foxp4 3.890 0.722 7 72.758
Q8R404 Protein QIL1 Qil1 2.812 0.722 6 13.373
Q86Y56 Dynein assembly factor 5, axonemal Heatr2 1.698 0.722 6 93.85
Q3TBW2 39 S ribosomal protein L10, mitochondrial Mrpl10 2.758 0.719 5 29.395
E9PWB1 Pleckstrin homology-like domain family B member 1 Phldb1 3.099 0.716 32 145.04
P70698 CTP synthase 1 Ctps1 3.766 0.715 29 66.682
Q3UMC0 Spermatogenesis-associated protein 5 Spata5 1.550 0.710 5 97.255
Q922Y1 UBX domain-containing protein 1 Ubxn1 3.403 0.709 8 33.572
Q8K4F6 Putative methyltransferase NSUN5 Nsun5 2.148 0.708 6 51.029
Q64261 Cyclin-dependent kinase 6 Cdk6 6.123 0.706 5 37.028
J3QP71 Basigin Bsg 2.028 0.703 7 21.602
Q99M31 Heat shock 70 kDa protein 14 Hspa14 3.418 0.701 13 54.65
Q63870 Collagen alpha-1(VII) chain Col7a1 3.142 0.699 13 295.23
A2A6Q5 Cell division cycle protein 27 homolog Cdc27 2.122 0.696 6 91.841
Q9CRA5 Golgi phosphoprotein 3 Golph3 1.933 0.691 9 33.752
Q9JIK5 Nucleolar RNA helicase 2 Ddx21 5.098 0.690 59 93.55
Q6ZPJ3 Ubiquitin-conjugating enzyme E2 O Ube2o 2.910 0.689 7 140.83
Q3UVH2 Tyrosine-protein kinase CSK Csk 2.833 0.687 12 50.73
Q63829 COMM domain-containing protein 3 Commd3 2.101 0.680 5 22.037
Q9R0H0 Peroxisomal acyl-coenzyme A oxidase 1 Acox1 2.545 0.675 14 74.717
Q3UA06 Pachytene checkpoint protein 2 homolog Trip13 1.747 0.670 8 48.376
Q8R3P6 von Willebrand factor A domain-containing protein 9 Vwa9 2.231 0.670 7 57.236
Q921Q7 Ras and Rab interactor 1 Rin1 1.329 0.664 4 83.013
P62488 DNA-directed RNA polymerase II subunit RPB7 Polr2g 2.233 0.663 7 19.294
Q6NS79 Protein diaphanous homolog 1 Diap1 2.186 0.662 16 135.84
Q8BL74 General transcription factor 3 C polypeptide 2 Gtf3c2 2.088 0.659 6 100.27
J3QMC5 Midasin Mdn1 2.800 0.659 41 629.58
Q91VJ4 Serine/threonine-protein kinase 38 Stk38 1.602 0.659 4 54.174
Q8R126 Gltscr2 protein Gltscr2 2.771 0.658 7 54.506
Continued
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and TNFα -induced NF-κ B activation, we focussed our attention on NDR1. To investigate the possibility that 
SOCS2 regulates NDR1, we first used immunoblotting (IB) to verify that depletion of SOCS2 by siRNAs indeed 
increased the cellular levels of endogenous NDR1 protein under resting conditions (Fig. 2A) and when de novo 
protein synthesis has been blocked using cycloheximide (Fig. 2B). Over-expressed FLAGSOCS2 could decrease 
endogenous NDR1 protein but not mRNA (Fig. 2C–E). Furthermore, FLAGSOCS2 could destabilize exogenously 
expressed MycNDR1 in MEFs in a dose-dependent manner (Fig. 2F) and in a panel of different cell lines (Fig. 2G). 
We also observed that FLAGSOCS2WT but not FLAGSOCS2ΔSB (deletion of SOCS box which is required for inter-
action with ElonginB/C and Cullin5 complex) mutants could decrease levels of endogenous NDR1 protein 
(Fig. 2H), suggesting that the SOCS-box domain is required for SOCS2 to regulate NDR1 abundance, likely medi-
ated through the Cullin5 E3 ligase. Consistently, depletion of Cullin5 increased NDR1 protein levels (Fig. 2I). 
Over-expressed MycNDR1 did not have any detectable effects on the total protein levels of exogenous FLAGSOCS2 
in MEFs (Fig. 2H). We also observed that the destabilizing effect of FLAGSOCS2 on MycNDR1 is further enhanced 
after treatment with TNFα (Fig. 2J). It is known that the interaction of SOCS2 with its target is mediated through 
phosphorylated tyrosine (Y) residue(s) on the substrate. Substitution of several of the Y residues on NDR1 with 
high probability of phosphorylation (source: PhosphoSitePlus database), could not abolish the ability of SOCS2 
to degrade NDR1 (Figure S1), suggesting requirement of either multiple phospho-Y sites or Y residues other than 
the mutated ones. Collectively, these data demonstrate that NDR1 protein is regulated by SOCS2.
SOCS2 interacts with NDR1 leading to its polyubiquitination. Consistent with a role of SOCS2 
in regulating NDR1 stability, over-expressed MycNDR1 was detected in exogenously expressed FLAGSOCS2ΔSB 
pull-down complexes and vice versa in HEK293T cells (Fig. 3A,B). We used a SOCS-box deleted form of SOCS2 
Majority 
protein IDs Protein names
Gene 
names
P value  
(−Log10)
Difference 
(Log2)
Unique 
peptides
Mol. weight 
[kDa]
Q3U8P5 Vacuolar protein sorting-associated protein 4B Vps4b 3.743 0.656 8 49.464
F8VQ54 Endoribonuclease Dicer Dicer1 1.684 0.655 7 215.77
P70444 BH3-interacting domain death agonist Bid 1.761 0.650 5 21.951
Q8C079 Striatin-interacting protein 1 Strip1 1.444 0.648 7 86.884
Q9EQ80 NIF3-like protein 1 Nif3l1 2.376 0.644 10 41.745
E9QAP7 Protein Taf Taf4a 1.489 0.643 5 73.137
Q3THE6 Ferritin Ftl1 3.246 0.628 2 20.695
Q3UUQ7 GPI inositol-deacylase Pgap1 2.451 0.628 2 104.58
Q3THG5 Cyclin-dependent kinase 7 Cdk7 1.353 0.626 4 38.968
Q9D071 MMS19 nucleotide excision repair protein homolog Mms19 1.478 0.626 8 97.458
Q9QY06 Unconventional myosin-IXb Myo9b 3.626 0.620 11 238.83
A3KMJ8 Prefoldin subunit 3 Vbp1 3.410 0.619 9 21.963
Q6ZQH8 Nucleoporin NUP188 homolog Nup188 2.879 0.618 21 196.69
Q9DC50 Peroxisomal carnitine O-octanoyltransferase Crot 1.812 0.617 6 70.264
Q5PPR2 Exocyst complex component 1 Exoc1 1.615 0.616 5 100.19
Q9CZD3 Glycine–tRNA ligase Gars 3.168 0.609 38 81.877
Q9CSZ1 BTB/POZ domain-containing protein KCTD5 Kctd5 1.377 0.606 2 18.877
Q8BVG4 Dipeptidyl peptidase 9 Dpp9 2.135 0.603 10 98
A6H5Z3 Exocyst complex component 6B Exoc6b 1.806 0.601 5 94.128
F8VQJ3 Laminin subunit gamma-1 Lamc1 3.495 0.601 24 177.19
Q9D358 Low molecular weight phosphotyrosine protein phosphatase Acp1 1.924 0.600 7 18.192
Q80VI1 E3 ubiquitin-protein ligase TRIM56 Trim56 2.562 0.598 10 79.512
Q3UHB1 5-nucleotidase domain-containing protein 3 Nt5dc3 2.245 0.598 11 63.17
P11440 Cyclin-dependent kinase 1 Cdk1 3.618 0.598 14 34.106
Q9JJY4 Probable ATP-dependent RNA helicase DDX20 Ddx20 1.349 0.597 8 91.709
Q99K58 Fibulin-2 Fbln2 1.933 0.596 6 126.46
Q8WTY4 Anamorsin Ciapin1 2.119 0.596 9 33.429
Q8BJ03 Cytochrome c oxidase assembly protein COX15 homolog Cox15 1.314 0.595 3 44.005
Q3TKX4 Probable ATP-dependent RNA helicase DDX52 Ddx52 2.903 0.595 20 67.129
Q9DB96 Neuroguidin Ngdn 2.196 0.594 5 35.658
Q5SWU9 Acetyl-CoA carboxylase 1 Acaca 3.318 0.593 26 265.25
P46664 Adenylosuccinate synthetase isozyme 2 Adss 3.358 0.591 25 50.02
Q6WKZ8 E3 ubiquitin-protein ligase UBR2 Ubr2 2.034 0.586 18 199.2
Table 1.  Upregulated proteins identified in the proteomics screen which satisfied the criteria of a fold-
change of >1.5 and P-value < 0.05.
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for the pull-down assays to prevent SOCS2-induced degradation of NDR1 and to avoid Cullin5-interacting 
proteins in the immunoprecipitation. This interaction was confirmed in MEFs under endogenous conditions 
(Fig. 3C). We previously observed that FLAGSOCS2 over-expression could decrease levels of endogenous NDR1. 
This effect of SOCS2 on NDR1 is reversed by MG132 (26 S proteasome inhibitor) treatment (Fig. 3D), indicating 
that SOCS2 triggered reduction in NDR1 requires activity of the 26 S proteasome. Indeed, we observed a quantita-
tive increase of high molecular weight polyubiquitinated forms of MycNDR1 upon FLAGSOCS2WT over-expression 
(Fig. 3E) but not FLAGSOCS2ΔSB over-expression (Fig. 3F) and these polyubiquitination was through K48-linkage 
(Fig. 3G). On the basis of above data, we propose that SOCS2 destabilizes NDR1 by promoting ubiquitination and 
its subsequent degradation by the 26 S proteasome.
SOCS2 deficiency stimulates NF-κB activation in response to TNFα. Because NDR1 potentiates 
NF-κ B signaling in the presence of TNFα ligand18, we wished to evaluate the effect of SOCS2 on this aspect of 
NDR1 function due to its potential implications for clarifying the mechanisms behind SOCS2 anti-inflammatory 
actions, as mentioned above. However, before delving on to the functional implications of SOCS2 perturba-
tions on NDR1-potentiated NF-κ B signaling, we first asked what is the role of SOCS2 in TNFα -induced NF-κ B 
activation in MEFs under our experimental conditions. IB analysis of cytoplasmic and nuclear extracts showed 
that MEFs depleted of SOCS2 (SOCS2KD) had significantly higher nuclear p65 levels, as compared to wild-type 
(SOCS2WT) cells, after stimulation with TNFα (Fig. 4A). We obtained similar results using high-content 
Figure 2. SOCS2 destabilizes NDR1. (A) Blots prepared in Fig. 1A were re-probed for NDR1. (B) MEFs were 
transfected with either a NT siRNA or si-SOCS2 #8 and 24 hrs later treated with cycloheximide for additional 
8 hours. Lysates were propped by IB. (C) MEFs were transfected with FLAG-SOCS2 plasmid. Lysates from 
three independent experiments were probed by IB. (D) Pixel densitometry values obtained using ImageJ and 
normalized against β -actin are shown as a bar graph representing mean ± SEM, *P value < 0.05. (E) QPCR 
analysis of NDR1 gene using total RNAs extracted from MEFs transfected with FLAG-SOCS2 or an empty 
vector (EV). 18S rRNA was used as internal control. (F) MEFs were transfected with a constant amount of a 
plasmid encoding Myc-NDR1 and an increasing amount of FLAG-SOCS2, while keeping the total amount of 
DNA equal using EV. IB was done using indicated antibodies. (G) Plasmid for Myc-NDR1 were co-transfected 
with either EV or FLAG-SOCS2 in a panel of different cell lines and lysates were probed by IB. (H) MEFs were 
transfected with Myc-NDR1 in combination with either FLAG-SOCS2 or FLAG-SOCS2-Δ SB plasmids as 
shown. Lysates were probed by IB. (I) RNAi mediated depletion of Cullin5 in MEFs and IB for NDR1.  
(J) Plasmid for Myc-NDR1 were co-transfected with either EV or FLAG-SOCS2 and treated with TNFα (10 ng/ml 
for 1 hour) as shown. Lysates were probed by IB. Full-length blots of 2C (SOCS2) and 2C (β -actin) blots are 
presented in Supplementary Figure S4.
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quantitative imaging (HCQI) (Figure S2A, B and Fig. 4B,C) which allowed detection of nuclear p65 quanti-
tatively in situ19,20. Consistently, SOCS2KD cells were hyper-responsive to TNFα ligand with respect to NF-κ B 
activity as determined by luciferase reporter assay (Fig. 4D) and changes in mRNA levels of the NF-κ B target 
gene IL-6 (Figure S2C and Fig. 4E). We also observed that SOCS2 depletion resulted in changes in proteins 
secreted by TNFα -stimulated MEFs that promoted NF-κ B transactivation in wild-type cells (i.e., in a paracrine 
manner) (Fig. 4F–I). We contextualize our in vitro data in an in vivo setting by using the murine DSS (dextran 
sodium sulphate) model of ulcerative colitis (UC)21 where TNFα is a major driving factor22. DSS-administered 
induction of UC has not been previously reported in SOCS2 knock-out (SOCS2−/−) mice. We found that in com-
parison to wild type mice, colonic tissue from SOCS2−/− mice showed exacerbated inflammation upon DSS treat-
ment (Fig. 4J,K). Consistently, we observed much stronger nuclear staining for p65 in SOCS2−/−, as compared 
to SOCS2WT, mice after DSS administration (Fig. 4L) which was reflected in higher transcript levels of known 
NF-κ B target genes, iNOS and IL-1β (Fig. 4M). As a whole, our observations indicate that SOCS2 depletion facil-
itates NF-κ B signaling.
NDR1-mediated TNFα-induced NF-κB transactivation is inhibited by SOCS2. Having observed 
that SOCS2 depletion promotes several aspects of TNFα -induced NF-κ B signaling in MEFs, we next asked how 
Figure 3. SOCS2 interacts with NDR1 and promotes its ubiquitin-mediated degradation.  
(A,B) FLAG-SOCS2-Δ SB and Myc-NDR1 were expressed in MEFs either alone or together. Lysates were 
immunoprecipitated with anti-Myc (9E10) antibody (A) or anti-FLAG M2 antibody (B) and subjected to 
SDS–PAGE followed by IB. (C) HEK293T cells grown to ~80% confluency were harvested. Lysates (2 mg) were 
subjected to IP with anti-IgG or anti-SOCS2 antibody followed by IB with the indicated antibodies. Values on 
the right are densitometric quantifications with the corresponding “Input” band taken as 1. (D) MEFs were 
transfected with FLAG-SOCS2 plasmid as shown. Cells were treated with 10 μ M MG132 or an equal volume 
of DMSO for 16 hrs before harvesting. Lysates were prepared and IB was done as previously. (E,F) Plasmids for 
HA-Strep-Ubiquitin and Myc-NDR1 were co-expressed in MEF cells with FLAG-SOCS2 (E) or FLAG-SOCS2 
and FLAG-SOCS2-Δ SB (F) as shown. Cells were treated with 10 μ M MG132 or an equal volume of DMSO for 
16 hrs before harvesting. Lysates were prepared from 36 hrs post-transfected cells and subjected to pull-down 
using StrepTactin resin followed by IB. (G) Plasmids for HA-Strep-Ubiquitin-K48 or K48R and Myc-NDR1 
were co-expressed in HEK293T cells with FLAG-SOCS2 as shown. Cells were treated with 10 μ M MG132 or an 
equal volume of DMSO for 16 hrs before harvesting. Lysates were prepared from 36 hrs post-transfected cells 
and subjected to pull-down using anti-Myc (9E10) antibody followed by IB. Lysates were probed by IB. Full-
length blot of 3D (NDR1) are presented in Supplementary Figure S4.
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Figure 4. SOCS2 inhibits TNFα-induced NF-κB signaling. (A) MEFs were transfected with either NT or 3 
different SOCS2 siRNAs. After 36 hours cells were treated with TNFα (10 ng/ml) for 45 mins and cytoplasmic 
and nuclear fractions were probed with the indicated antibodies. (B) MEFs were transfected with NT or SOCS2 
siRNA as shown. After 36 hrs cells were treated with TNFα (10 ng/ml) for 45 mins or left untreated before 
being processed for immunofluorescence microscopy against p65 using HCQI. Scale bar represents 100 μ m. 
(C) Automated unbiased quantitation of nuclear p65 staining intensity was done using the ScanR software. 
Mean fluorescence intensity of p65 per nucleus for each ‘plate’ were determined. Data is representative of 
two independent experiments and depicts relative fold change ± standard error. (D) MEFs grown in 60 mm 
dishes were transfected with NT or SOCS2 siRNA along with pGL4.10-NF-κ B (100 ng) and pGL4.74-(hRluc/
TK (10 ng) as shown. After 36 hrs cells were either treated with TNFα (10 ng/ml for 6 hrs) or left untreated. 
Bar graph represents normalized luciferase readings against Renilla reporter activity for three independent 
experiments. (E) Q–PCR analysis of NF-κ B target gene IL-6 was performed using total RNAs extracted from 
MEFs transfected with NT or SOCS2 siRNAs and treated with TNFα (10 ng/ml for 1 hour). 18S rRNA was used 
as internal control. (F) Schematics of the treatments of MEFs for preparing conditioned media (CM).  
(G) Serum-starved MEFs were exposed to CM prepared above for 1 hour before being processed as in  
(B) and quantitated as in (C). (H) Serum starved (16 hrs) PC3 cells were treated as in (G) with the indicated CM 
and quantified as in (C). (I) Serum-starved MEFs were exposed to CM, prepared as in (F) with the exception 
that parthenolide was added to the cells together with TNFα as indicated, for 1 hour before being processed 
as in (B) and quantitated as in (C). (J) Schematics showing the DSS treatment for inducing ulcerative colitis 
in mice. (K) Representative images of colon tissues from SOCS2+/+ and SOCS2−/− mice exposed to DSS as 
indicated in (J) and probed for p65 using immunohistochemistry. (L) Histology scoring for colitis based on 
multiple parameters (see Methods section). White boxes on each image represent a staining index quantified by 
ImmunoRatio web application using default parameters47. Scale bars represent 200 μ m. (M) Q–PCR analysis of 
the indicated genes in total RNA isolated from colonic tissues of SOCS2+/+ and SOCS2−/− mice exposed to DSS 
as indicated in (D). For all Figures, *P value < 0.05 and **P value < 0.005.
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does this correlate to NDR1. In MEFs, transient over-expression of NDR1 amplifies TNFα -induced NF-κ B sign-
aling (Figure S3A–C). Consistently, depletion of NDR1 causes reduction of NF-κ B dependent luciferase activity 
in both presence and absence of external TNFα stimulation, although the effect is more pronounced in pres-
ence of TNFα (Fig. 5A,B). Using HCQI we show that over-expression of NDR1 and down-regulation of SOCS2 
had a combined additive effect on TNFα -induced nuclear translocation of p65 (Fig. 5C). Further, depletion of 
SOCS2 increased luciferase readout over TNFα stimulation alone, while knock-down of either NDR1 or double 
knock-down of both NDR1 and SOCS2 reduced NF-κ B luciferase reporter activity below that of TNFα treatment 
(Fig. 5D) suggesting NDR1 to be downstream of SOCS2. Conversely, SOCS2 over-expression should diminish 
the strengthened transactivation potential of NF-κ B in response to TNFα . To test this, we measured mRNA 
levels of well-known NF-κ B target genes (MCP-1, NFKB1A and Arginase-1) using quantitative real-time PCR 
(qPCR) analysis upon NDR1 and SOCS2 overexpression either alone or in combination in MEFs (Fig. 5E). We 
observed that overexpression of SOCS2 alone stimulated the transcription of these genes. This is not unexpected 
given these genes may not be exclusively regulated by NF-κ B under resting conditions and apparently depend on 
unidentified factors that are influenced by SOCS2. Nevertheless, NDR1 had an augmenting effect on the tran-
scription of all the genes tested, and importantly, in all instances SOCS2 truncated this effect (Fig. 5E). We also 
provide a correlative support to our in vitro observations by showing that inflamed SOCS2−/− colonic tissues iso-
lated from DSS-treated mice had elevated total levels of NDR1 protein as compared to similarly treated wild-type 
mice (Fig. 5F,G).
As a whole, our observations potentially point towards an explanation for the effects of SOCS2 on NF-κ B 
activity and the hyper-inflammatory phenotype of SOCS2 deficient animals.
NDR1 amplifies the aggressive behaviour of PC3 cells. We previously observed that SOCS2 acts 
as a tumour suppressor in advanced castration-resistant prostate cancer. Bone metastases clinical samples of 
human patients exhibit reduced levels of SOCS2 in comparison with localized or hormone naive untreated ade-
nocarcinomas23. A majority of these advanced tumors are known to have an elevated dependency on NF-κ B 
signaling for their survival24. Since SOCS2 deficiency could lead to an elevated NDR1 levels, we wanted to see 
how an “over-expressing” NDR1 protein itself would impinge on the tumorigenic properties of cancer cells. 
As per our knowledge this has not been tested before. For this we selected PC3 prostate cancer cells, partly 
Figure 5. SOCS2 inhibits TNFα-NDR1-NF-κB axis. (A) Efficacy testing of siRNAs in MEFs against NDR1 
using IB. (B) MEFs were transfected with NT siRNA or NDR1 siRNAs. After 36 hrs cells were treated with 
TNFα (10 ng/ml) for 1 hour and luciferase assay was performed as in Fig. 4D. (C) MEFs were cotransfected with 
a plasmid for Myc-NDR1 and SOCS2 siRNA as shown. After 36 hrs cells were treated with TNFα (10 ng/ml)  
for 1 hour before being fixed and processed for HCQI. Nuclear p65 intensity values were quantified and plotted 
as in Fig. 1C. (D) HEK293T cells were transfected with NT or SOCS2 siRNA (human) as shown and luciferase 
assay was performed as in Fig. 4D. (E) Quantitative RT-PCR analysis of NF-κ B target genes was performed 
using total RNAs extracted from MEFs transfected with FLAG-SOCS2 & Myc-NDR1 and treated with TNFα 
(10 ng/ml for 1 hour) or left untreated as shown. (F) Evaluation of endogenous protein levels of NDR1 using 
IB in extracts prepared from colonic tissues of SOCS2+/+ and SOCS2−/− mice, pre- and post-DSS insult as 
shown. (G) Pixel densitometry values of NDR1 bands obtained using ImageJ and normalized against GAPDH 
are shown as a bar graph. SE values are averages of densitometry readings from two representative mice. For all 
Figures, *P value < 0.05 and **P value < 0.005.
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because of their “addiction” to NF-κ B signaling25,26. To determine whether NDR1 over-expression alters the 
anchorage-independent growth of PC3 cells we performed soft-agar colony-formation assay and observed 
a marked difference in the number of colony-forming units. NDR1-overexpression in PC3 cells (PC3-NDR1) 
potentiated sphere-forming capacity by ~2.9-fold as compared to cells transfected with empty vector (PC3-EV) 
(Fig. 6A). However, PC3-NDR1 cells did not appear to have a significantly altered cell cycle profile in comparison 
to PC3-EV cells as measured using FACS analysis (Fig. 6B). PC3-NDR1 cells also had relatively higher invasive 
potential through Matrigel chamber (Fig. 6C). We next performed 2-dimensional wound-healing assay to test the 
migratory behaviour of these cells and found that PC3-NDR1 cells repopulated the cell-free clearing produced 
by the scratch faster than PC3-EV cells, indicating an increased migration rate. Importantly, inclusion of the 
NF-κ B inhibitor parthenolide abrogated wound-healing capacity of both PC3-EV and PC3-NDR1 cells (Fig. 6D) 
highlighting the crucial role played by NF-κ B in these cells. Taken together, these data demonstrate that NDR1 
might act as a driver of oncogenic growth in NF-κ B addicted tumors, although further research is needed to fully 
justify this claim.
Discussion
As mentioned above, the intracellular mechanisms by which anti-inflammatory actions are exerted by SOCS2 are 
poorly understood. This problem is related with our scarce knowledge of its cellular targets. To shed light on this 
aspect, we performed an unbiased nanoLC-MS/MS based quantification of cellular proteins in MEFs after tran-
sient knock-down of SOCS2 and enlisted 136 upregulated proteins. Of note, based on this experimental design 
we cannot rule out the contribution of secondary effects to changes in protein concentration, and the numbers of 
direct targets of SOCS2 are likely to be lower. Thus, additional research is needed to establish whether and how 
proteins identified in this analysis as putative SOCS2 targets are indeed ubiquitinated by SOCS2 and how they 
contribute to its cellular functions, including inflammation. Nonetheless, as it stands, this is the first report of a 
global quantitative proteomics effort specifically directed towards identification of SOCS2 regulated proteins.
Our proteomic data revealed NDR1 as a potential target for SOCS2 ubiquitin ligase activity. NDR1 (or STK38) 
is a serine-threonine kinase. It belongs to the LATS/NDR family and controls many critical processes including 
centrosome duplication27, apoptosis and proliferation28, chromosome alignment29. It regulates signaling pathways 
such as MEKK1/230, TGFβ 31, Hippo32 and TLR933. Recently, NDR1 was shown to potentiate NF-κ B signaling in 
the presence of TNFα ligand in HEK293T and HeLa cells18. Evidences indicate NDR1 protein is highly regulated 
through phosphorylation32 and the ubiquitin proteasome system31. Several kinases, including MST134 and GSK3β 35  
are known to regulated NDR1 activity under various contexts. However, no physiological E3 ligase had yet been 
reported for NDR1.
Using immunoprecipitation, we show that SOCS2 and NDR1 exist in the same complex. NDR1 was found 
to be a substrate of wild-type SOCS2 but not a SOCS-box truncated form i.e., SOCS2-Δ SB. SOCS2 acts as the 
Figure 6. NDR1 acts as an oncogene in PC3 cells. (A) Representative images of soft-agar colony formation 
assay in PC3 cells transfected with EV or NDR1 plasmid. Bar graph displays data from three independent 
experiments and represents mean ± standard error. (B) Cell cycle profile from FACS analysis of cells transfected 
as in (A). (C) Representative images of matrigel invasion assay of PC3 cells transfected as in (A). Bar graph 
displays data from three independent experiments and represents mean ± standard error. (D) Representative 
images of “wound-healing” assay in PC3 cells transfected as in (A) and treated with NF-κ B inhibitor 
parthenolide as shown. Numbers in insets represents cell count within the “box”.
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substrate recognition module of Cullin5/Rbx2 E3 ligase “holoenzyme” and depends on its C-terminus SOCS 
box to interact with the complex, suggesting the involvement of Cullin5 E3 ligase. Consistently, knock-down of 
Cullin5 using RNAi stabilized NDR1 protein. Overexpression of SOCS2 increases polyubiquitination of NDR1 
subsequently targeting it to 26S proteasomes as indicated by an increased ubiquitin-NDR1 conjugates in pres-
ence of MG132. We also provide data to support that SOCS2 ubiquitination of NDR1 is mediated mainly by 
K48-Ub-specific linkages that are mostly associated with proteolysis. Conversely, our data showing stabilization 
of NDR1 upon SOCS2 depletion indicates a constitutive ligase-substrate relation between them.
Considering some of the latest evidences, it appears that SOCS2 probably orchestrates multiple regulatory 
nodes in the inflammatory pathway8,36–38. We observed that over-expression of NDR1 alone had a two-fold 
enhancing effect on NF-κ B transactivation, as judged by qPCR of well-known NF-κ B target genes. Not surpris-
ingly, the overall impact was much stronger when the cells were induced with TNFα but the fold change was still 
~2.0 fold. Therefore, our report agrees with Shi et al., that NDR1 potentiates TNFα induced NF-κ B signaling, 
however, the mechanism behind this effect is yet to be uncovered. Here we report SOCS2 induced destabiliza-
tion of NDR1. SOCS2 can constitutively degrade NDR1 without an activating stimulus (other than provided by 
standard cell culture conditions), although interestingly, a TNFα stimulus seem to make NDR1 a better target of 
SOCS2. Based on our proteomics observations, we believe that NDR1 protein is relatively more abundant than 
SOCS2 because we repeatedly detected NDR1 by mass spectrometry analysis but not SOCS2. This might mean 
that manipulating SOCS2 levels may serve a switch for controlling TNFα -NF-κ B signaling mediated through 
NDR1.
We offered evidence that SOCS2 regulation of NDR1 may be relevant for inflammation and carcinogenesis. 
Our observations showing elevated tumorigenic properties of PC3 cells in response to NDR1 over-expression 
raises interesting questions and begs further research into the carcinogenic role of NDR1. Given the role of NF-κ B 
signaling in multiple human malignancies, our study raises the potential for SOCS2-NDR1-NF-κ B axis as a target 
for drug discovery in inflammation and cancer biology.
Overall, the data presented in this study (1) provides evidence for an inhibitory role of SOCS2 in TNFα 
induced NF-κ B activation, (2) identifies NDR1 as a novel substrate of SOCS2, and (3) demonstrates that SOCS2 
and TNFα induced NF-κ B signaling are linked through NDR1. Through this study, we provide a mechanistic 
explanation for the well-acknowledged hyper-inflammatory phenotype of SOCS2-deficient animals (Fig. 7).
Materials and Methods
Cell Culture, transfection and drug treatments. Cells were cultured using standard protocols. 
Transfections of DNA constructs and siRNAs were performed using Neon® Transfection System (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. The following drugs/inhibitors were used: MG132, 
cycloheximide (Sigma-Aldrich), mouse and human recombinant TNFα (Invitrogen). Concentrations used and 
incubation times are given in Figure legends.
Expression plasmids and siRNA. Human SOCS2 gene (NM_003877) was PCR amplified from 
total HEK293T cDNA. Full-length SOCS2 and SOCS2ΔSB deletion mutant (amino acids 1–145) were cloned 
into pcDNA 4/TO vector with an N-terminal FLAG epitope to generate FLAGSOCS2WT and FLAGSOCS2ΔSB. 
pcDNA4/TO-HA-Strep-ubiquitin WT, K48-only and K48R were a kind gift from Niels Mailand (University of 
Copenhagen). Myc-tagged NDR1 was obtained from Addgene (Plasmid #37023, a kind gift from Yutaka Hata). 
Point mutations of Myc-NDR1 were created using the site-directed mutagenesis kit (Agilent Technologies) as per 
manufacturer’s instructions. All plasmids were verified by sequencing. Sequences of primers used can be provided 
upon request. All siRNAs were purchased from Qiagen and used at a final concentration of 80 nM. Sequences are 
given in Table S2.
Figure 7. A simplified model of SOCS2 mediated regulation of TNFα - NF-κB signaling through NDR1 
ubiquitination and degradation. 
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Preparation of conditioned medium. Cells were starved in serum-free media for 16 hours before being 
pulsed with TNFα (10 ng/ml) for 1 hour after which residual TNFα was washed twice using PBS. Serum-free 
media was again replenished and cells were inubated for another 4 hours. CM were collected, clarified by centrif-
ugation and passed through sterile 0.22 μ m sterile filter. CM were used freshly.
Co-immunoprecipitation (co-IP) and immunoblot (IB) analyses. For co-IP experiments, cells were 
lysed on ice using IP buffer (50 mM HEPES, pH 7.2, 250 mM NaCl, 10% glycerol, 1% Nonidet P-40, 1.0 mM 
EDTA, 10 mM phenylmethanesulfonylfluoride (PMSF), 50 mM sodium fluoride, 0.2 mM sodium orthovana-
date (Na3VO4), 25 mM β -glycerophosphate and protease inhibitor cocktail from Roche). After pre-clearing with 
Protein A Sepharose beads (Amersham Biosciences), 2 mg of total protein was subjected to immunoprecipitation 
as described previously39. For western blotting, cells were lysed on ice using RIPA buffer (50mM Tris pH 7.4, 
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X 100, 10 mM phenylmethanesulfonylfluoride 
(PMSF), 50 mM sodium fluoride, 0.2 mM sodium orthovanadate (Na3VO4), 25 mM β -glycerophosphate and pro-
tease inhibitor cocktail from Roche). The following antibodies were used: Santacruz Biotechnology - GAPDH, 
Myc (9E10), NDR1(STK38), Ubiquitin; Sigma - β -actin, HA, FLAG(M2); Abcam – SOCS2; Abnova – NDR1; Cell 
Signaling Technology – SOCS2, p65, FLAG. Pixel densitometric measurements of immunoblots was done using 
the ImageJ software (https://fiji.sc/).
Orbitrap Q-Exactive MS/MS and proteomics data analysis. Lysates were prepared as described pre-
viously40. From each sample, 100 μ g of proteins were first digested with Lys-C (4 hours at 37 °C) followed by dilu-
tion of guanidine hydrochloride to < 2 M with 50 mM ammonium bicarbonate prior to the addition sequencing 
grade Trypsin (overnight at 37 °C). Enzyme activity was quenched by acidification of the samples with trifluoro-
acetic acid (TFA) and the peptide mixture was desalted and concentrated on a C18 Stagetip before elution with 
50% acetonitrile, 0.1% TFA. The eluate was concentrated in a SpeedVac at 60 °C and acidified with 5% ACN, 1% 
TFA before being analyzed using an EASY-nLC system (Proxeon) connected to a Q Exactive mass spectrometer 
(Thermo Fisher Scientific) through a nano-electrospray ion source. Peptides were separated in a 15-cm analytical 
column (75 μ m inner diameter) in-house packed with 1.9 μ m diameter reversed-phase C18 beads (ReproSil-Pur 
AQ, Dr. Maisch) with an increasing gradient from 5 to 30% buffer B (80% acetonitrile, 0.1% formic acid) in 
120 minutes at a flow rate of 250 nl/min followed by an increase to 40% B in 15 minutes where it was briefly 
held prior to 80% B for 5 minutes followed by column re-equilibration at 5% B. The Q-Exactive was operated in 
data-dependent acquisition mode using the “sensitive scanning method”41. Raw MS files from the Q-Exactive 
were analyzed by MaxQuant 1.4.1.1 with the Andromeda search engine42. Tandem mass spectrometry spectra 
were searched against the decoy International Protein Index-Mus musculus database version 3.62 containing both 
forward and reverse protein sequences. The search included variable modifications of methionine oxidation and 
N-terminal acetylation, and fixed modification of cysteine carbamidomethylation. Peptides of minimum seven 
amino acids and maximum of two missed cleavages were allowed for the analysis. False discovery rate of 1% was 
used for the identification of peptides and proteins. Bioinformatics analysis of the data were mainly performed 
using the Perseus computational platform43 and text mining in PubMed using the search string: ((NF-κ B[Title]) 
AND gene1[Title]) OR gene2[Title] etc. for all identified proteins with a P-value < 0.05 and Fold change > 1.5.
Luciferase assays. Luciferase activity of NF-κ B reporter was determined luminometrically using the 
Dual-Glo luciferase assay system (Promega). MEFs (106) were transiently transfected with pGL4.74-hRluc/TK 
(10 ng) and pGL4.10.NF-κ B reporter (100 ng) vectors along with the indicated constructs. Luciferase activity 
of cell extracts in passive lysis buffer was determined luminometrically using the Varioskan multiplate reader 
(Thermo Fisher Scientific).
Microscopy. Protocol has been described before39. For High-Content Quantitative Imaging (HCQI), pho-
tographs were captured on Olympus IX-81 motorized fluorescence microscope equipped with an Olympus 
UPLSAPO 20x/0.75 NA objective. Automated and unbiased image analysis was carried out with the ScanR acqui-
sition software. For confocal fluorescence microscopy, images were captured on a Zeiss LSM 700 imaging system.
Quantitative real-time PCR (qPCR). Total RNA was extracted using the RNeasy kit (Qiagen). For each 
sample, 1 μ g of RNA was converted to cDNA using iScript cDNA synthesis kit (Biorad), diluted 1:5 with water and 
subsequently used for qPCR analysis using Brilliant III ultra-fast SYBR® green (Agilent Technologies) on a 7500 
Fast Real-Time PCR system (Applied Biosystems). In all experiments, 18S rRNA served as the internal control 
(normalization) and calibrator controls were chosen appropriately. Sequences of the primers used are given in 
Table S3.
Immunohistochemistry. Tissue sections were deparaffinized in xylene and rehydrated through graded 
ethanol. For antigen retrieval slides were steamed for 30 minutes in EnVision FLEX Target Retrieval Solution 
(pH 6.1) (Dako). Antibody incubations were done overnight at 4 °C in Shandon coverplates (Thermo Fisher 
Scientific). For detection, HiDef HRP polymer system (Sigma-Aldrich) was used followed by incubation with 
DAB + chromogen (DAKO) according to manufacturer’s instructions. Slides were counterstained with Mayers 
hematoxylin for 1 minute. All immunohistochemical procedures were undertaken in one batch. The antibody for 
p65 was from Cell Signaling Technology.
Laboratory Animals and Experimental Colitis. Mice were housed under standard conditions 
[12:12-hour light-dark cycles, 22 ± 2 °C and about 60% humidity] with ad libitum feeding. Male SOCS2 knock-
out (SOCS2− /− ) and SOCS2-wild type (SOCS2+ /+ ) littermate mice between 12–16 weeks’ old were used 
and they were allowed to acclimate to these conditions for a week before the start of the experiment. Colonic 
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inflammation was induced by oral administration of 3% (w/v) Dextran Sodium Sulfate (DSS; T&D consulting, 
Uppsala, Sweden) dissolved in drinking water for 5 days and then switched to normal drinking water until day 
20. Mice were sacrificed after euthanasia by total bleeding and cervical dislocation after anesthesia by isoflurane. 
Entire colons of DSS treated and untreated mice were dissected and contents flushed with ice-cold saline. The 
distal third of the colon was dissected into equal pieces for histological analysis and RNA & protein extractions. 
Following H + E staining, specimens were evaluated for histological colitis scoring by two independent patholo-
gist using light microscopy. The scoring of histological changes in the colon was done according to Cooper et al.44, 
which include the assessment of Crypt loss, infiltration of neutrophil, lymphocytes and goblet cell depletion45,46. 
Histological findings were given a score based on the severity of the colitis (Table S4). Animal handling and all 
experimental protocols were performed in accordance with the relevant guidelines and regulations approved by 
the “Animal Ethics Committee” of Sultan Qaboos University, Oman.
Soft-agar colony formation assay. For soft-agar assays, 300 cells were suspended in RPMI containing 
0.35% agar and layered on top of 1 ml of RPMI solidified with 1.0% agar in each 35-mm dish. After growing at 
37 °C for 14 days, colonies were visualized and counted in three different microscopic fields.
Wound healing assay. The migratory behavior of PC3 cells were evaluated using the scratch (wound heal-
ing) assay. Briefly, equal number of cells were seeded on 6-well plates and allowed to reach confluency. Several 
scratches were made using a 200 μ l pipette tip spanning the well. Migration of cells was observed at premarked 
positions below the wells using an Olympus IX81 inverted microscope at 40X magnification.
Matrigel invasion assay. Matrigel (60 μ l at 1:4 dilutions in RPMI medium) was coated on the top of 
Transwell filters (6.5-mm diameter, 8.0-μ m pore size, Costar, Corning, NY) for 4 h at 37 °C. Chemoattractant 
(10 ng/ml TNFα ) was added to bottom chambers of transwells and cells (50,000) were plated on Matrigel in RPMI 
and allowed to migrate overnight at 37 °C through Matrigel. Migrated cells were fixed in 4% paraformaldehyde in 
PBS for 15 minutes and permeabilized with 0.2% Triton -X100 in PBS for 10 minutes. Cells migrated to the lower 
chamber were stained with 0.5 μ g/ml DAPI in PBS. Fluorescence pictures were acquired using an Olympus IX81 
inverted microscope at 40X magnification from three random fields and nuclei were counted using ImageJ.
Statistical analysis. All statistical calculations were done using the GraphPad QuickCalcs software. 
Student’s t-test (unpaired) was used. A P value of < 0.05 was taken as significant and < 0.005 was considered 
extremely significant. For proteomics experiments, P values were calculated using the inbuilt statistical functions 
of Perseus platform.
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